Molecular Analysis of HER2 Signaling in Human Breast Cancer by Functional Protein Pathway Activation Mapping
Julia Wulfkuhle(University of California, San Francisco), Emanuel F. Petricoin(Center for Biologics Evaluation and Research), Angela DeMichele(University of Pennsylvania), Holger Bronger(Technical University of Munich), Kai Tran(University of California, San Francisco), Karl‐Friedrich Becker(University of Bonn), Claudia Wolff(University of California, San Francisco), Laura J. Esserman(University of California, San Francisco), Daniela Berg(Christian-Albrechts-Universität zu Kiel), Axel Walch(Unknown), Julie Illi(University of California, San Francisco), Ingrid Becker(University of California, San Francisco), Virginia Espina(George Mason University), Lance A. Liotta(George Mason University), Rupert Langer(Johannes Kepler University of Linz), Jianghong Deng(Capital Medical University), Heinz Höfler(Klinikum rechts der Isar), Mariaelena Pierobon(George Mason University), Christine Waldhör(University of California, San Francisco)
Cited by 124
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer
|New England Journal of Medicine|2018|1.3k